Dolby Laboratories (DLB): Price and Financial Metrics


Dolby Laboratories (DLB)

Today's Latest Price: $73.00 USD

0.94 (1.30%)

Updated Feb 19 12:00am

Add DLB to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 35 in Technology - Electronics

See all "A" rated Strong Buy stocks

DLB Stock Summary

  • The ratio of debt to operating expenses for Dolby Laboratories Inc is higher than it is for about merely 0.37% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.21 for Dolby Laboratories Inc; that's greater than it is for only 12.05% of US stocks.
  • The volatility of Dolby Laboratories Inc's share price is greater than that of only 16.8% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Dolby Laboratories Inc, a group of peers worth examining would be CGNX, ACIW, DIOD, VNDA, and HXL.
  • Visit DLB's SEC page to see the company's official filings. To visit the company's web site, go to www.dolby.com.
DLB Daily Price Range
DLB 52-Week Price Range

DLB Stock Price Chart More Charts


DLB Price/Volume Stats

Current price $73.00 52-week high $73.11
Prev. close $72.06 52-week low $56.09
Day low $72.34 Volume 366,200
Day high $73.10 Avg. volume 416,600
50-day MA $69.34 Dividend yield 1.21%
200-day MA $65.19 Market Cap 7.37B

Dolby Laboratories (DLB) Company Bio


Dolby Laboratories creates audio, imaging, and communication technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company was founded in 1965 and is based in San Francisco, California.

DLB Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$73.00$10.27-86%

Below please find a table outlining a discounted cash flow forecast for DLB, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Dolby Laboratories Inc ranked in the 16st percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 85.83%. The most interesting components of our discounted cash flow analysis for Dolby Laboratories Inc ended up being:

  • The company's compound free cash flow growth rate over the past 5.75 years comes in at -0.06%; that's greater than only 20.82% of US stocks we're applying DCF forecasting to.
  • The business' balance sheet suggests that 1% of the company's capital is sourced from debt; this is greater than only 6.73% of the free cash flow producing stocks we're observing.
  • The company's cost of debt, derived from its interest coverage, tax rate, and market capitalization, is greater than merely 0% of stocks in its sector (Consumer Cyclical).


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-86%
1%-86%
2%-86%
3%-86%
4%-86%
5%-85%

Want more companies with a valuation profile/forecast similar to that of Dolby Laboratories Inc? See BXG, FRGI, GFASY, BBBY, and BLL.


DLB Latest News Stream


Event/TimeNews Detail
Loading, please wait...

DLB Latest Social Stream


Loading social stream, please wait...

View Full DLB Social Stream

DLB Price Returns

1-mo 6.32%
3-mo 5.88%
6-mo 21.10%
1-year 13.36%
3-year 52.71%
5-year 92.51%
YTD 6.43%
2019 12.63%
2018 0.78%
2017 38.73%
2016 35.83%
2015 -21.07%

DLB Dividends

Ex-Dividend DateTypePayout AmountChange
Loading, please wait...
View Full DLB Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9335 seconds.